Use this form to apply for initial or switching PBS-subsidised treatment with eculizumab or ravulizumab for aHUS.
You must download our forms and fill them in so they are processed quickly. You can also electronically sign some of our forms. We have help available if you use assistive technology or need an interpreter.
You can upload this form in HPOS.
Download and complete the atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - initial or switching authority application form.
This information was printed 16 July 2025 from https://www.servicesaustralia.gov.au/pb119. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/site-notices when using this material.